Cite
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
MLA
Janssen, Maike, et al. “A Randomized Open Label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A Structured Summary of a Study Protocol for a Randomised Controlled Trial.” Trials, vol. 21, no. 1, Oct. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s13063-020-04735-y.
APA
Janssen, M., Schäkel, U., Djuka Fokou, C., Krisam, J., Stermann, J., Kriegsmann, K., Haberbosch, I., Novotny, J. P., Weber, S., Vehreschild, M., Bornhäuser, M., Bullinger, L., Schmitt, M., Liebregts, T., Dreger, P., Lorenz, H.-M., Plaszczyca, A., Bartenschlager, R., Müller, B., & Kräusslich, H.-G. (2020). A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial. Trials, 21(1), N.PAG. https://doi.org/10.1186/s13063-020-04735-y
Chicago
Janssen, Maike, Ulrike Schäkel, Carine Djuka Fokou, Johannes Krisam, Jacek Stermann, Katharina Kriegsmann, Isabella Haberbosch, et al. 2020. “A Randomized Open Label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A Structured Summary of a Study Protocol for a Randomised Controlled Trial.” Trials 21 (1): N.PAG. doi:10.1186/s13063-020-04735-y.